Question

Difficulty: Very hardObstetric Complications

Evaluate the following complex laboratory and clinical profiles of pregnant patients presenting with hepatic or hematologic dysfunction. Pair each patient presentation with its most precise underlying pathophysiologic mechanism.

  • 36-week gestation, severe nausea, right upper quadrant pain, profound hypoglycemia (glucose 42 mg/dL), prolonged prothrombin time (PT), and elevated ammonia.Microvesicular fatty infiltration of hepatocytes often driven by an underlying fetal mitochondrial fatty acid oxidation defect.
  • 38-week gestation, hypertension, severe right upper quadrant pain, platelet count 45,000/mm³, normal coagulation profile (PT/PTT), and AST 500 U/L.Systemic microvascular endothelial activation and dysfunction resulting in localized hepatic sinusoid fibrin cross-linking and platelet consumption.
  • 24-week gestation, new-onset confusion, fever, profound thrombocytopenia (12,000/mm³), severe hemolytic anemia, normal coagulation profile, and elevated creatinine.Autoantibody-mediated inhibition of a specific metalloproteinase, leading to uncleaved ultra-large von Willebrand factor multimers.
  • 35-week gestation, intense unremitting pruritus predominantly on palms and soles, elevated serum transaminases, completely normal platelet count, and normal coagulation profile.Impaired hepatocyte canalicular transport causing accumulation of cholic and chenodeoxycholic acids in the systemic circulation.

Answer

The presentations map to their underlying mechanisms as follows: The patient with hypoglycemia and prolonged PT matches microvesicular fatty infiltration (AFLP). The patient with hypertension, low platelets, but normal PT/PTT matches systemic endothelial activation (HELLP). The patient with confusion, fever, and extreme thrombocytopenia matches ADAMTS13 metalloproteinase inhibition (TTP). The patient with pruritus and normal platelets matches impaired hepatocyte canalicular transport (ICP).
Acute fatty liver of pregnancy (AFLP) is defined by microvesicular fat deposition leading to synthetic liver failure (hypoglycemia, prolonged PT). HELLP syndrome is driven by endothelial injury causing platelet consumption, but maintains normal PT/PTT and glucose. Thrombotic thrombocytopenic purpura (TTP) is caused by ADAMTS13 deficiency, resulting in severe thrombocytopenia and neurologic signs without consuming clotting factors. Intrahepatic cholestasis of pregnancy (ICP) results from defective bile acid transport, causing isolated severe pruritus.

Step-by-Step Solution

1
Evaluate coagulation status (PT/PTT) and glucose levels to differentiate AFLP from HELLP syndrome.
The profile with prolonged PT and hypoglycemia indicates true hepatic synthetic failure, which points to Acute Fatty Liver of Pregnancy (AFLP). The profile with low platelets and elevated AST but normal PT/PTT points to HELLP syndrome.
Differentiating third-trimester hepatic dysfunction requires assessing synthetic liver function. HELLP primarily causes hepatocellular necrosis and platelet consumption, whereas AFLP causes widespread hepatocyte dysfunction leading to failure of gluconeogenesis and clotting factor production.
2
Analyze the profile featuring neurologic symptoms and fever.
Confusion, fever, and extreme thrombocytopenia without consumptive coagulopathy (normal PT/PTT) identifies Thrombotic Thrombocytopenic Purpura (TTP).
While HELLP can cause low platelets, the profound thrombocytopenia combined with neurologic deficits and fever—without significant transaminitis—is the classic pentad for TTP.
3
Identify the primary symptom in the remaining normocoagulant profile.
Intense palmar/plantar pruritus with normal platelets and coagulation factors identifies Intrahepatic Cholestasis of Pregnancy (ICP).
ICP is an isolated defect in bile acid transport causing severe itching, unlike the other conditions which feature significant hematologic or synthetic liver compromise.

Key Concept

Differentiating severe hepatic and hematologic complications of pregnancy based on synthetic liver function (glucose, PT/PTT) and specific clinical hallmarks (neurologic changes, extreme pruritus).
Rate this question